Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm.
about
Human papillomavirus-associated cancers: a survey on otorhinolaryngologists' knowledge and attitudes on preventionEpidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell CarcinomaPrevalence of Human Papillomavirus in Oropharyngeal Cancer: A Systematic ReviewDetection of HPV infection in head and neck squamous cell carcinoma: a practical proposalDiagnostic accuracy of p16INK4a immunohistochemistry in oropharyngeal squamous cell carcinomas: A systematic review and meta-analysis.Human Papillomavirus and Head and Neck Cancer: Psychosocial Impact in Patients and Knowledge of the Link - A Systematic Review.Management of locally advanced HPV-related oropharyngeal squamous cell carcinoma: where are we?Population-based incidence trends of oropharyngeal and oral cavity cancers by sex among the poorest and underprivileged populations.Six-month incidence and persistence of oral HPV infection in HIV-negative and HIV-infected men who have sex with men.A comprehensive assessment protocol including patient reported outcomes, physical tests, and biological sampling in newly diagnosed patients with head and neck cancer: is it feasible?Human polyomavirus and human papillomavirus prevalence and viral load in non-malignant tonsillar tissue and tonsillar carcinoma.Prognostic significance of high-risk human papillomavirus and p16(INK4A) in patients with esophageal squamous cell carcinoma.Twelve-month incidence and clearance of oral HPV infection in HIV-negative and HIV-infected men who have sex with men: the H2M cohort studyCorrelation of LMP10 expression and clinical outcome in Human Papillomavirus (HPV) positive and HPV-Negative tonsillar and base of tongue cancerDetection of HPV-associated oropharyngeal tumours in a 16-year cohort: more than meets the eye.Direct benefit of vaccinating boys along with girls against oncogenic human papillomavirus: bayesian evidence synthesisThe rationale for HPV-related oropharyngeal cancer de-escalation treatment strategiesComparison of the miRNA profiles in HPV-positive and HPV-negative tonsillar tumors and a model system of human keratinocyte clones.Stromal infiltration of CD8 T cells is associated with improved clinical outcome in HPV-positive oropharyngeal squamous carcinoma.Clinical relevance of copy number profiling in oral and oropharyngeal squamous cell carcinomaLow prevalence of human papillomavirus in head and neck squamous cell carcinoma in the northwest region of the Philippines.Different prognostic models for different patient populations: validation of a new prognostic model for patients with oropharyngeal cancer in Western Europe.Print and online newspaper coverage of the link between HPV and oral cancer in the UK: a mixed-methods studyA beneficial tumor microenvironment in oropharyngeal squamous cell carcinoma is characterized by a high T cell and low IL-17(+) cell frequencyNew insights into human papillomavirus-associated head and neck squamous cell carcinoma.Discussing a diagnosis of human papillomavirus oropharyngeal cancer with patients: An exploratory qualitative study of health professionals.Human papillomavirus as a potential risk factor for gastric cancer: a meta-analysis of 1,917 cases.Understanding HPV tests and their appropriate applications.Incidence and clinical management of oral human papillomavirus infection in men: a series of key short messages.Viral infections and colorectal cancer: a systematic review of epidemiological studies.The prevalence of human papillomavirus in squamous cell carcinoma of unknown primary site metastatic to neck lymph nodes: a systematic review.Prevention of HPV-Related Oral Cancer by Dentists: Assessing the Opinion of Dutch Dental Students.Applications of molecular diagnostics for personalized treatment of head and neck cancer: state of the art.Disease burden of human papillomavirus infection in the Netherlands, 1989-2014: the gap between females and males is diminishing.Establishment and characterization of a human papillomavirus type 16-positive tonsillar carcinoma xenograft in BALB/c nude mice.p16(INK4a) /Ki-67 co-expression specifically identifies transformed cells in the head and neck region.HPV Testing of Head and Neck Cancer in Clinical Practice.Risk Groups for Survival in HPV-Positive and HPV-Negative OPSCC.Toll-like receptor 5 and 7 expression may impact prognosis of HPV-positive oropharyngeal squamous cell carcinoma patients.Anal HPV 16 and 18 viral load: a comparison between HIV-negative and HIV-positive MSM and association with persistence.
P2860
Q26768614-CBFFC537-8A1A-4FC1-AB0F-474E23518BC9Q26782499-9F14EE67-7FC9-42DD-BE17-17061B435ABAQ26851922-B0C114F3-5C6C-4967-8FB5-9747A52A42B3Q28287388-64DCA02E-E9E6-4272-9EF5-7275325F75DEQ30241076-10992696-4AE2-48CB-9272-800E9E847478Q30251750-3A992864-CCAE-4960-BA2C-6AF1D3A0D840Q30252081-6E17BE28-2395-4CBE-93DE-75C613597D59Q33617596-F2B29167-999A-4EF5-A36D-D31A6D4B5A3AQ33712114-25BD2381-4CC2-4EAE-901F-0DA0E53B5A36Q34446641-F5D97927-395A-48E8-B2D4-487A1C86D41AQ34544410-A955E75C-370F-4F17-A319-F021D68B917DQ34547715-DE72C5F1-E870-448C-B3DD-8AC3D95F35D6Q34986850-78E0E247-8D70-473F-841E-6638DB27825BQ35154161-CAD9F975-2BC8-492C-9609-10E8CB320C02Q35475603-50CD911B-ACEA-4BE9-B56B-045309DE66FEQ35596183-B72A3E58-AA22-4B7D-9702-EFBBAF108C0BQ35838231-2FB55489-EC91-4852-94ED-22ECF59603A7Q36067876-7C9E14E8-1EC1-46E3-B4B6-391C48FD772DQ36081369-4188CFFF-10EC-482E-AA9A-F7B590F62BE7Q36201478-89A322EB-5648-4B93-B793-90CB0DCF21D3Q36281407-55672B22-198B-4DB1-BE16-3C3F44B7E1F7Q36285958-84497C69-4D99-4133-8347-CBE087F31960Q36625269-C7470D02-B1DF-4025-A86E-1D2563375F39Q36783066-A50CEA89-1894-4B9F-A65B-D968E4197D21Q36880375-0FC34615-217B-4F62-8626-337EFD0ED0F3Q37275499-57B029F7-757E-42E2-BF33-22BD91BEADDFQ37429164-74D4F86D-3E81-4ADD-9E0F-2FBF4129EE3CQ38133612-51A5EFB3-AD83-4EB9-AA7D-CA1ABF5ED34AQ38215252-2DA13F69-1A32-442B-B394-564EF36A223CQ38245947-E5ECCD3D-82F4-4BD3-9C94-9589C58D1FBFQ38584576-B1CDFFFC-F9A6-4B41-9348-A735881A857DQ38652233-7E18CBB2-A4F6-4F4F-9841-C8FA58297BC7Q38653658-A1ABE695-27D2-4E32-9EB5-9DD4822EC5DEQ38755899-DE0CA26F-78C3-4E87-A08D-51EFCB18948DQ38944279-CF6918F9-1FF2-4162-9A6B-24CEF95EB3F3Q38967902-F9B90515-DFC0-4A0F-83E0-78676A7B35F0Q38971546-ABA7A472-7112-4E1A-AD55-D8A4A6C31A29Q38971577-E11086AE-7D68-4974-8586-4BE9A02EE291Q40063898-B90171D3-8C98-46B9-A2CE-CDCF897ED974Q40126055-141C7961-F74E-4199-998B-0AB62AB436E2
P2860
Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Increasing prevalence rates of ...... by a validated test algorithm.
@en
Increasing prevalence rates of ...... by a validated test algorithm.
@nl
type
label
Increasing prevalence rates of ...... by a validated test algorithm.
@en
Increasing prevalence rates of ...... by a validated test algorithm.
@nl
prefLabel
Increasing prevalence rates of ...... by a validated test algorithm.
@en
Increasing prevalence rates of ...... by a validated test algorithm.
@nl
P2093
P2860
P356
P1476
Increasing prevalence rates of ...... by a validated test algorithm
@en
P2093
Albertus T Hesselink
Birgit I Witte
Boudewijn J M Braakhuis
C René Leemans
Chris J L M Meijer
Daniëlle A M Heideman
Michelle M Rietbergen
Peter J F Snijders
Ruud H Brakenhoff
P2860
P304
P356
10.1002/IJC.27821
P577
2012-11-23T00:00:00Z